Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Most people on isotretinoin had chapped lips, but only a few stopped the medicine due to side effects.

All-trans retinoic acid slows cell growth and increases cell death in goat hair follicles through a specific pathway.

A microemulsion with Carthamus tinctorius extract effectively inhibits 5α-reductase and improves skin and hair follicle delivery.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Oral isotretinoin effectively treated the man's painful scalp condition and hair loss.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

Nanocarriers improve acne treatment by enhancing drug delivery and reducing side effects.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Higher doses of isotretinoin may lead to more hair loss.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

TREM2 macrophages and unsaturated lipids contribute to acne inflammation.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Both treatments work equally well for hair regrowth, but the lotion has fewer side effects.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.